COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI was delisted on the 3rd of September, 2025.
10 hedge funds and large institutions have $106K invested in COSCIENS Biopharma Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
61% more capital invested
Capital invested by funds: $65.8K → $106K (+$39.8K)
0.07% more ownership
Funds ownership: 0.18% → 0.25% (+0.07%)
17% less funds holding
Funds holding: 12 → 10 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$21.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.2K |
| 3 |
Morgan Stanley
New York
|
+$193 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$154 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$5.58K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$582 |
| 3 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$385 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$377 |
| 5 |
JP Morgan Chase
New York
|
-$231 |
CSCI Hedge Fund Activity: Q1 2024 in Review
10 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q1 2024, worth a combined $106K — up 61% from $65.8K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CSCI and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $21.3K. The largest seller was Group One Trading, exiting entirely with an estimated $5.58K sold.
- 10 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q1 2024, down from 12 in Q4 2023.
- Funds reported $106K of COSCIENS Biopharma Inc. Common Stock stock for Q1 2024, up 61% quarter-over-quarter.
- 2 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q1 2024 and 4 closed out, a net change of -2 holders.
- The largest COSCIENS Biopharma Inc. Common Stock buyer in Q1 2024 was Bank of Montreal, an estimated $21.3K added.
- The largest COSCIENS Biopharma Inc. Common Stock seller in Q1 2024 was Group One Trading, an estimated $5.58K sold.
Based on aggregated 13F filings for Q1 2024.